Is the prevalence of antibiotic-resistant organisms changing in Canadian hospitals? Comparison of point-prevalence survey results in 2010 and 2012  V.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Gram-positive infections: lessons learnt and novel solutions
New epidemiology of Staphylococcus aureus infection in Asia
Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors  S. Amit, H. Mishali, T. Kotlovsky,
R. Cantón, A. Novais, A. Valverde, E. Machado, L. Peixe, F. Baquero, T
M.F.Q. Kluytmans-VandenBergh, J.A.J.W. Kluytmans 
Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience  H. Asgeirsson, A. Thalme, M. Kristjansson,
Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients 
Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to.
European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years.
The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram- positive bacteria  M.J. Rybak  Clinical Microbiology and Infection 
European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Data review and recommendations for diagnosing Clostridium difficile-infection.
European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after.
Clinical impact of antibiotic-resistant Gram-positive pathogens
Cost-effectiveness of universal MRSA screening on admission to surgery
Clonal complex 398 methicillin-susceptible Staphylococcus aureus bloodstream infections are associated with high mortality  K. Bouiller, H. Gbaguidi-Haore,
Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals 
Clinical impact and prevalence of MRSA CC398 and differences between MRSA-TetR and MRSA-TetS in an area of Spain with a high density of pig farming: a.
A.E. Muller, U. Theuretzbacher, J.W. Mouton 
Longitudinal investigation of nasopharyngeal methicillin-resistant Staphylococcus aureus colonization in early infancy: The PATCH birth cohort study 
Extended-spectrum β-lactamase/AmpC- and carbapenemase-producing Enterobacteriaceae in animals: a threat for humans?  J.-Y. Madec, M. Haenni, P. Nordmann,
Cost analysis of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers in the context of diagnosis.
Use of surveillance cultures and enteral vancomycin to control methicillin-resistant Staphylococcus aureus in a paediatric intensive care unit  K. Thorburn,
W. Witte, B. Pasemann, C. Cuny  Clinical Microbiology and Infection 
A multicentre analysis of epidemiology of the nosocomial bloodstream infections in Japanese university hospitals  M. Nagao  Clinical Microbiology and.
Rapid genotyping of methicillin-resistant Staphylococcus aureus (MRSA) isolates using miniaturised oligonucleotide arrays  S. Monecke, R. Ehricht  Clinical.
Do we need new antibiotics?
Quantamatrix Multiplexed Assay Platform system for direct detection of bacteria and antibiotic resistance determinants in positive blood culture bottles 
Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals  C. Nonhoff, O. Denis,
Secular trends of bloodstream infections during neutropenia in 15 181 haematopoietic stem cell transplants: 13-year results from a European multicentre.
A variant of the Southern German clone of methicillin-resistant Staphylococcus aureus is predominant in Croatia  A. Budimir, R.H. Deurenberg, Z. Bošnjak,
Bacterial resistance—the clinical challenge
Strategies for managing today's infections
Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the community  R.E. Warren, G. Harvey, R. Carr, D. Ward,
Evaluation of vancomycin MIC creep in methicillin-resistant Staphylococcus aureus infections—a systematic review and meta-analysis  R. Diaz, V. Afreixo,
Four-year epidemiological study of extended-spectrum β-lactamase-producing Enterobacteriaceae in a French teaching hospital  L. Gibold, F. Robin, R.-N.
M. Aires-de-Sousa  Clinical Microbiology and Infection 
Clinical profile of ceftobiprole, a novel β-lactam antibiotic
Risk factors for extended-spectrum β-lactamase-producing Escherichia coli urinary tract infection in the community in Denmark: a case–control study  M.
Laboratory diagnosis of Clostridium difficile disease
Systematic review of antibiotic consumption in acute care hospitals
Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases  L. Romero, L. López,
Y. Tveten, A. Jenkins, A.G. Allum, B.-E. Kristiansen 
Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to.
B. Y. Lee, A. Singh, M. Z. David, S. M. Bartsch, R. B. Slayton, S. S
Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals  G.L. Cartolano,
A.W. Karchmer  Clinical Microbiology and Infection 
P.M. Hawkey  Clinical Microbiology and Infection 
Increased incidence of methicillin-resistant Staphylococcus aureus ST80, novel ST125 and SCCmecIV in the south-eastern part of Norway during a 12-year.
Evolving problems with resistant pathogens
S. M. Bartsch, J. A. McKinnell, L. E. Mueller, L. G. Miller, S. K
Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013  U. Fedeli, E. Schievano,
G.M. Rossolini, E. Mantengoli  Clinical Microbiology and Infection 
R. Cantón, A. Novais, A. Valverde, E. Machado, L. Peixe, F. Baquero, T
J.-M. Rolain, C. Abat, P. Brouqui, D. Raoult 
W. Eugene Sanders, Christine C. Sanders 
Rise and subsequent decline of community-associated methicillin resistant Staphylococcus aureus ST30-IVc in Copenhagen, Denmark through an effective search.
E. Tacconelli  Clinical Microbiology and Infection 
J. Wilson, S. Elgohari, D. M. Livermore, B. Cookson, A. Johnson, T
A. Manzur, F. Gudiol  Clinical Microbiology and Infection 
Impact of antibiotics on the intestinal microbiota needs to be re-defined to optimize antibiotic usage  E. Ruppé, C. Burdet, N. Grall, V. de Lastours,
Antibiotic overconsumption and resistance in Turkey
B.A. Cunha  Clinical Microbiology and Infection 
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
D.A. Robinson, M.C. Enright  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Impact of a targeted isolation strategy at intensive-care-unit-admission on intensive- care-unit-acquired infection related to multidrug-resistant bacteria:
CMI readers' survey Clinical Microbiology and Infection
Secular trends of bloodstream infections during neutropenia in 15 181 haematopoietic stem cell transplants: 13-year results from a European multicentre.
Presentation transcript:

Is the prevalence of antibiotic-resistant organisms changing in Canadian hospitals? Comparison of point-prevalence survey results in 2010 and 2012  V. Williams, A.E. Simor, A. Kiss, A. McGeer, Z. Hirji, O.E. Larios, C. Moore, K. Weiss  Clinical Microbiology and Infection  Volume 21, Issue 6, Pages 553-559 (June 2015) DOI: 10.1016/j.cmi.2015.01.024 Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 Median (range) prevalence (per 100 inpatients) of methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae (CRE) and Clostridium difficile infection (CDI) in Canada, 2012. Clinical Microbiology and Infection 2015 21, 553-559DOI: (10.1016/j.cmi.2015.01.024) Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.